Humatrope Growth Hormone Pen is an injectable medication containing recombinant human growth hormone (somatropin) used to treat growth hormone deficiency in children and adults, as well as certain other conditions that cause growth failure. The pen is designed for ease of use and accurate dosing.

Instructions for Use:

1. Composition: Each Humatrope pen contains 72 IU (24mg) of somatropin in a ready-to-use format.
2. Dosage: The dosage varies depending on the condition being treated, patient age, weight, and response to therapy. Consult with a healthcare professional for personalized dosage recommendations.
3. Administration: Administer the growth hormone subcutaneously using the Humatrope pen. Rotate injection sites to minimize the risk of local irritation or tissue atrophy.
4. Preparation: Follow the specific instructions provided with the Humatrope pen for preparing and administering the injection. Ensure the pen is primed and the correct dose is set before each use.
5. Monitoring: Regularly monitor growth progress, IGF-1 levels, and any potential side effects during treatment. Adjust dosage as directed by your healthcare provider.
6. Potential Side Effects: Be aware of possible side effects, including injection site reactions, swelling, joint pain, headaches, and in rare cases, increased intracranial pressure. Report any severe or unusual symptoms to your healthcare provider.
7. Special Considerations: Use with caution in patients with diabetes, as somatropin can affect glucose metabolism. Inform your healthcare provider of any other medications or conditions.
8. Storage: Store the Humatrope pen in a refrigerator at 2-8°C (36-46°F). Do not freeze. After first use, some pens may be stored at room temperature as directed by the manufacturer, but most should be kept refrigerated.

Consultation Reminder: Always consult with a healthcare professional before using growth hormone therapy to ensure safe and appropriate use, particularly in the treatment of hormone deficiencies or growth-related conditions.